<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Ianalumab on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/ianalumab/</link><description>Recent content in Ianalumab on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sat, 24 Oct 2026 06:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/ianalumab/index.xml" rel="self" type="application/rss+xml"/><item><title>Ianalumab in Sjögren's Disease: NEPTUNUS-1 and -2</title><link>https://rheumatologydigest.org/posts/ianalumab-sjogren-neptunus/</link><pubDate>Sat, 24 Oct 2026 06:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/ianalumab-sjogren-neptunus/</guid><description>Ianalumab monthly beat placebo on ESSDAI in two phase 3 trials, but by only 1–1.3 points, with no clear gain in responders or symptoms.</description></item></channel></rss>